Real-life studies and registries of severe asthma: The advent of digital technology

Asthma is a chronic disorder of the lower airways affecting over 300 million people worldwide [1]. A majority of those with asthma are treated in primary care and their asthma can be controlled with inhaled corticosteroids (ICS) and bronchodilators. Approximately 5 –10 % of patients are uncontrolled despite high dose ICS treatment or require high dose ICS treatment to remain controlled [2]. These patients often receive multiple courses of oral corticosteroids (OCS) and it is now clear that both long-term and repeated acute courses of OCS increase the risk of serious adverse effects, such as osteoporosis, metabolic disorders, and cardiovascular complications [3].
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Tags: Original Research Source Type: research